Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy.

Werier J, Yao X, Caudrelier JM, Di Primio G, Ghert M, Gupta AA, Kandel R, Verma S.

Surg Oncol. 2016 Mar;25(1):16-23. doi: 10.1016/j.suronc.2015.11.002. Epub 2015 Dec 11. Review.

PMID:
26979636
2.

Evidence-based guideline recommendations on treatment strategies for localized Ewing's sarcoma of bone following neo-adjuvant chemotherapy.

Werier J, Yao X, Caudrelier JM, di Primio G, Ghert M, Gupta AA, Kandel R, Verma S.

Surg Oncol. 2016 Jun;25(2):92-7. doi: 10.1016/j.suronc.2016.03.006. Epub 2016 Mar 25.

PMID:
27312034
3.

[Treatment of pelvic Ewing's sarcoma in children and the effect on the skeletal growth and development].

Fu J, Guo Z, Wang Z, Li XD, Li J, Chen GJ, Wu ZG.

Zhonghua Zhong Liu Za Zhi. 2012 Dec;34(12):927-31. doi: 10.3760/cma.j.issn.0253-3766.2012.12.010. Chinese.

PMID:
23336380
4.

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.

Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Müller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Göbel U, Treuner J, Voûte PA, Zoubek A, Gadner H, Jürgens H.

J Clin Oncol. 2001 Mar 15;19(6):1818-29.

PMID:
11251014
5.

[Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy].

Peng RJ, Sun XF, Xiang XJ, Zhen ZJ, Ling JY, Tong GL, Xia Y, Xu GC, Jiang WQ.

Ai Zheng. 2009 Dec;28(12):1304-9. Chinese.

PMID:
19958626
6.

Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.

Ataergin S, Ozet A, Solchaga L, Turan M, Beyzadeoglu M, Oysul K, Arpaci F, Komurcu S, Surenkok S, Ozturk M.

Med Oncol. 2009;26(3):276-86. doi: 10.1007/s12032-008-9115-6. Epub 2008 Nov 7.

PMID:
18989798
7.

Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group.

Daecke W, Ahrens S, Juergens H, Martini AK, Ewerbeck V, Kotz R, Winkelmann W, Bernd L.

J Cancer Res Clin Oncol. 2005 Apr;131(4):219-25. Epub 2004 Dec 22.

PMID:
15614525
8.

Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.

Biswas B, Rastogi S, Khan SA, Shukla NK, Deo SV, Agarwala S, Sharma DN, Thulkar S, Vishnubhatla S, Pathania S, Bakhshi S.

Clin Oncol (R Coll Radiol). 2014 Nov;26(11):722-9. doi: 10.1016/j.clon.2014.05.006. Epub 2014 Jun 8.

PMID:
24919857
9.

Chemotherapy for children with medulloblastoma.

Michiels EM, Schouten-Van Meeteren AY, Doz F, Janssens GO, van Dalen EC.

Cochrane Database Syst Rev. 2015 Jan 1;1:CD006678. doi: 10.1002/14651858.CD006678.pub2. Review.

PMID:
25879092
10.

Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.

Tural D, Molinas Mandel N, Dervisoglu S, Oner Dincbas F, Koca S, Colpan Oksuz D, Kantarci F, Turna H, Selcukbiricik F, Hiz M.

Jpn J Clin Oncol. 2012 May;42(5):420-6. doi: 10.1093/jjco/hys027. Epub 2012 Mar 12.

PMID:
22416252
11.

Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.

Ferrari S, Mercuri M, Rosito P, Mancini A, Barbieri E, Longhi A, Rimondini S, Cesari M, Ruggieri P, Di Liddo M, Bacci G.

J Chemother. 1998 Dec;10(6):484-91.

PMID:
9876058
12.

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.

Bacci G, Ferrari S, Bertoni F, Rimondini S, Longhi A, Bacchini P, Forni C, Manfrini M, Donati D, Picci P.

J Clin Oncol. 2000 Jan;18(1):4-11.

PMID:
10623687
13.

Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.

Schuetze SM.

J Natl Compr Canc Netw. 2007 Apr;5(4):449-55. Review.

PMID:
17442235
14.

Efficacy Comparison of Six Chemotherapeutic Combinations for Osteosarcoma and Ewing's Sarcoma Treatment: A Network Meta-Analysis.

Zhang T, Zhang S, Yang F, Wang L, Zhu S, Qiu B, Li S, Deng Z.

J Cell Biochem. 2018 Jan;119(1):250-259. doi: 10.1002/jcb.25976. Epub 2017 Oct 4. Review.

PMID:
28266080
15.

No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.

Bacci G, Picci P, Ruggieri P, Ferrari S, Mercuri M, Fabbri N, Rosito P, Barbieri E, Ferraro A, Casadei R, et al.

J Chemother. 1993 Aug;5(4):247-57.

PMID:
8229153
16.

Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.

Bacci G, Ferrari S, Bertoni F, Donati D, Bacchini P, Longhi A, Brach Del Prever A, Forni C, Rimondini S.

J Clin Oncol. 2000 Feb;18(4):885-92.

PMID:
10673532
17.

Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.

Albergo JI, Gaston CL, Laitinen M, Darbyshire A, Jeys LM, Sumathi V, Parry M, Peake D, Carter SR, Tillman R, Abudu AT, Grimer RJ.

Bone Joint J. 2016 Aug;98-B(8):1138-44. doi: 10.1302/0301-620X.98B8.37346.

PMID:
27482030
18.

Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years.

Bacci G, Ferrari S, Comandone A, Zanone A, Ruggieri P, Longhi A, Bertoni F, Forni C, Versari M, Rimondini S.

Acta Oncol. 2000;39(1):111-6.

PMID:
10752664
19.
20.

Ewing sarcoma of the hand or foot.

Froeb D, Ranft A, Boelling T, Paulussen M, Klco-Brosius S, Jürgens H, Dirksen U.

Klin Padiatr. 2012 Oct;224(6):348-52. doi: 10.1055/s-0032-1327607. Epub 2012 Nov 9.

PMID:
23143762

Supplemental Content

Support Center